Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BVS-LATE: Optimal Antiplatelet Duration After BVS Implantation
NCT02939872Phase 4Completed
- Start
- Mar 2017
- Primary completion
- May 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of aspirin in coronary artery disease (CAD) (2 arms). Primary endpoint: Composite event of death, myocardial infarction, or stroke at 1 year. Started Mar 2017; status: completed.
02
Drugs
aspirin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02939872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02939872.